Akebia to host conference call at 8:00 a.m. ET on May 9 Vafseo® (vadadustat) tablets FDA approved on March 27, 2024 Vafseo launch activities underway with availability expected in January 2025 ...

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...

The clinical introduction of hepcidin25 (Hep25) has led to a more detailed understanding of its relationship with ferroportin (FP) and divalent metal transporter1 in primary iron overload syndromes ...

Liver disease, hereditary, passed through families. Factors like viral infections, alcohol, obesity lead to liver damage, ...

A blood transfusion helps treat anemia by replacing RBCs to alleviate symptoms and prevent harmful health consequences.

Hemochromatosis. • Wilson's disease. • Alpha-1 antitrypsin deficiency. Various tests that help in taking precautions A1ALC Test: It stands for Alpha-1-Antitrypsin Prototype S/Z by LC-MS/MS ...

If your iron levels are low, taking a supplement can help you combat fatigue, cold hands and feet and other symptoms tied to ...

Hemochromatosis is a condition that causes a buildup of iron in the blood. This can lead to dysfunction in various organs. The main treatment for hemochromatosis is phlebotomy. Phlebotomy involves ...

Pregnant or breastfeeding people and children shouldn't take shilajit in any form. As noted above, it is also best to avoid shilajit if you have hemochromatosis or concerns with testosterone. It is ...

P.T., J.T.S.); and the Department of Medicine, University of Helsinki, Helsinki, Finland (K.K., T.H.). Background—Homozygosity for a relatively common Cys282Tyr mutation of the human ...

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. Here’s our process. This article discusses hemp and CBD gummies ...

Four fifths of 49 patients with chronic, severe anemia from birth have manifested, usually during the second decade, signs of hemochromatosis with cardiac involvement. Nineteen patients had 33 attacks ...